ClariveinTM is a new endovenous method of treating varicose veins that combines both mechanical and chemical treatment, otherwise known as Mechanico-Chemical Ablation (MOCATM).
The procedure is performed in a similar manner to ELVA, except that no tumescent anaesthesia is required and no thermal heating of the tissues occurs.
Under ultrasound guidance, a special catheter with rotating inner wire is inserted into the vein to be treated. The wire rotates to disrupt the epithelial lining of the vein, allowing the liquid sclerosant to become in more contact and penetrate the lining of the vein. The whole procedure is performed through a single incision, with minimal local anaesthetic being used.
The advantage of Clarivein over other therapies, such as Endovenous Laser Ablation, is that it is faster (20 min rather than 60 min), does not use thermal ablation, and can be used in patients who have allergies or sensitivities to local anaesthesia.
Clarivein is still a relatively new treatment and thus, long-term data is not available. However, early analysis is showing excellent results, approaching those of EVLA and surpassing those of surgery and UGFS. Recovery from the procedure is also very quick, with patients being able to return to normal activity the same day.
Dr Matar has travelled to Melbourne to learn the Clarivein technique from Australian endovascular pioneer, Professor Ken Myers, and has also spent time with Professor Ian Spark and his team in Adelaide, who have the greatest experience in Australia with this revolutionary technique.
The vein clinic is the first clinic in Western Australia to offer this new technology to the people of Perth. To learn more about how Clarivein works, watch the video above, or contact us.